[go: up one dir, main page]

GB8928837D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB8928837D0
GB8928837D0 GB898928837A GB8928837A GB8928837D0 GB 8928837 D0 GB8928837 D0 GB 8928837D0 GB 898928837 A GB898928837 A GB 898928837A GB 8928837 A GB8928837 A GB 8928837A GB 8928837 D0 GB8928837 D0 GB 8928837D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898928837A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB898928837A priority Critical patent/GB8928837D0/en
Publication of GB8928837D0 publication Critical patent/GB8928837D0/en
Priority to IE460390A priority patent/IE904603A1/en
Priority to ZA9010219A priority patent/ZA9010219B/xx
Priority to KR1019920701481A priority patent/KR920703037A/ko
Priority to JP3502103A priority patent/JPH05502872A/ja
Priority to PCT/GB1990/001996 priority patent/WO1991009593A2/fr
Priority to CA002071994A priority patent/CA2071994A1/fr
Priority to EP91901843A priority patent/EP0506813A1/fr
Priority to AU70516/91A priority patent/AU7051691A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
GB898928837A 1989-12-21 1989-12-21 Pharmaceuticals Pending GB8928837D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB898928837A GB8928837D0 (en) 1989-12-21 1989-12-21 Pharmaceuticals
IE460390A IE904603A1 (en) 1989-12-21 1990-12-19 Pharmaceuticals
ZA9010219A ZA9010219B (en) 1989-12-21 1990-12-19 5-ht3 antagonists for treat of nausea,bradycardia of hypotension associated with myocardial instability
KR1019920701481A KR920703037A (ko) 1989-12-21 1990-12-20 심근 불안정과 관련된 저혈압증, 구기, 서맥의 치료를 위한 5-ht₃길항질
JP3502103A JPH05502872A (ja) 1989-12-21 1990-12-20 医薬
PCT/GB1990/001996 WO1991009593A2 (fr) 1989-12-21 1990-12-20 Antagonistes 5-ht3 de traitement de la nausee de la bradycardie de l'hypotension associee a une instabilite du myocarde
CA002071994A CA2071994A1 (fr) 1989-12-21 1990-12-20 Specialites pharmaceutiques
EP91901843A EP0506813A1 (fr) 1989-12-21 1990-12-20 Antagonistes 5-ht 3? de traitement de la nausee de la bradycardie de l'hypotension associee a une instabilite du myocarde
AU70516/91A AU7051691A (en) 1989-12-21 1990-12-20 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928837A GB8928837D0 (en) 1989-12-21 1989-12-21 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB8928837D0 true GB8928837D0 (en) 1990-02-28

Family

ID=10668280

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898928837A Pending GB8928837D0 (en) 1989-12-21 1989-12-21 Pharmaceuticals

Country Status (9)

Country Link
EP (1) EP0506813A1 (fr)
JP (1) JPH05502872A (fr)
KR (1) KR920703037A (fr)
AU (1) AU7051691A (fr)
CA (1) CA2071994A1 (fr)
GB (1) GB8928837D0 (fr)
IE (1) IE904603A1 (fr)
WO (1) WO1991009593A2 (fr)
ZA (1) ZA9010219B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
GB9305593D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
EP1432707B1 (fr) 2001-10-02 2012-03-28 Pharmacia & Upjohn Company LLC Composes d'heteoraryle fusionne substitues par azabicyclo utiles pour le traitement de maladies
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
JP2005510523A (ja) 2001-11-09 2005-04-21 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー アザ二環式フェニル縮合複素環式化合物、及びα７ＮＡＣＨＲリガンドとしての当該化合物の使用
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US6852716B2 (en) 2002-02-15 2005-02-08 Pfizer Inc Substituted-aryl compounds for treatment of disease
US6858613B2 (en) 2002-02-19 2005-02-22 Pfizer Inc. Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
US6894042B2 (en) 2002-02-19 2005-05-17 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
AU2003276919B2 (en) 2002-09-25 2013-05-16 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
PL1697378T3 (pl) 2003-12-22 2008-04-30 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
US20050234095A1 (en) 2004-03-25 2005-10-20 Wenge Xie Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
WO2006001894A1 (fr) 2004-04-22 2006-01-05 Memory Pharmaceutical Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, leur preparation et leurs utilisations
US7632831B2 (en) 2004-05-07 2009-12-15 Memory Pharmaceuticals Corporation 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
US7576094B2 (en) 2004-12-13 2009-08-18 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors
JP2008525464A (ja) 2004-12-22 2008-07-17 メモリー・ファーマシューティカルズ・コーポレイション α−７ニコチン性受容体リガンド並びにその製造及び使用
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
CA2799744C (fr) * 2010-05-17 2020-01-28 Envivo Pharmaceuticals, Inc. Forme cristalline de monohydrate d'hydrochlorure de (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide
US9585877B2 (en) 2012-05-08 2017-03-07 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
DE19375046I2 (de) * 1984-01-25 2002-10-10 Glaxo Group Ltd 1,2,3,9-Tetrahydro-3-Ä(1H-imidazol-1-yl)methylÜ-4H-carbazol-4-one Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
EP0498466B1 (fr) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Dérivés d'indazole-3-carboxamide et de l'amide-3-carboxylique
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
GB8701494D0 (en) * 1987-01-23 1987-02-25 Glaxo Group Ltd Chemical compounds
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
FR2616149B1 (fr) * 1987-06-04 1990-10-19 Adir Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
DE3851597T2 (de) * 1987-09-03 1995-01-26 Glaxo Group Ltd., London Lactamderivate.
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
EP0315390B1 (fr) * 1987-11-04 1994-07-20 Beecham Group Plc Composés nouveaux de 4-oxobenzotriazine et 4-oxoquinazoline
DE3740984A1 (de) * 1987-12-03 1989-06-15 Sandoz Ag N-oxide von heterocyclischen carbonsaeurederivaten bzw. verfahren zu deren herstellung und deren verwendung
ZA889166B (en) * 1987-12-10 1990-05-30 Duphar Int Res 1,7-annelated indolecarboxylic acid esters and -amides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
EP0350129A1 (fr) * 1988-07-07 1990-01-10 Duphar International Research B.V Indole cétones annelées avec un substituant imidazolylalkyle
IT1226389B (it) * 1988-07-12 1991-01-15 Angeli Inst Spa Nuovi derivati ammidinici e guanidinici
FR2639944B1 (fr) * 1988-12-06 1991-01-18 Adir Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2004911A1 (fr) * 1988-12-22 1990-06-22 Mitsuaki Ohta Derives de 4,5,6,7-tetrahydrobenzimidazole
IT1228288B (it) * 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica

Also Published As

Publication number Publication date
AU7051691A (en) 1991-07-24
CA2071994A1 (fr) 1991-06-22
JPH05502872A (ja) 1993-05-20
WO1991009593A3 (fr) 1991-09-05
KR920703037A (ko) 1992-12-17
WO1991009593A2 (fr) 1991-07-11
ZA9010219B (en) 1991-11-27
IE904603A1 (en) 1991-07-03
EP0506813A1 (fr) 1992-10-07

Similar Documents

Publication Publication Date Title
GB8926560D0 (en) Pharmaceuticals
GB8927872D0 (en) Pharmaceuticals
AU111543S (en) Can
GB8928837D0 (en) Pharmaceuticals
AU5342290A (en) Cd8-based pharmaceuticals
GB9026164D0 (en) Pharmaceuticals
GB9027487D0 (en) Pharmaceuticals
GB9027098D0 (en) Pharmaceuticals
ZA912744B (en) Pharmaceuticals
EP0409350A3 (en) Certain glyoxyl-cyclohexendiones
CS343490A3 (en) Pharmaceutical
GB8927695D0 (en) Pharmaceuticals
GB8909932D0 (en) Pharmaceuticals
GB8926783D0 (en) Pharmaceuticals
GB8927873D0 (en) Pharmaceuticals
GB8927875D0 (en) Pharmaceuticals
GB8907782D0 (en) Pharmaceuticals
ZA911435B (en) Pharmaceuticals
CA63452S (en) Tablet
CA63421S (en) Tablet
CA63453S (en) Tablet
CA64087S (en) Tablet
GB9022262D0 (en) Pharmaceuticals
GB9027897D0 (en) Pharmaceuticals
GB9025979D0 (en) Pharmaceuticals